Failure of Direct-Acting Antiviral Agents Due to Incomplete Hepatitis C Virus Genotyping
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, cilt.24, sa.3, ss.96-98, 2018 (ESCI, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 24 Sayı: 3
- Basım Tarihi: 2018
- Doi Numarası: 10.4274/vhd.2018.0022
- Dergi Adı: VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.96-98
- Anahtar Kelimeler: Chronic hepatitis C, direct-acting antivirals, hepatitis C virus, RESISTANCE
- Ankara Üniversitesi Adresli: Evet
Özet
Current direct acting antivirals (DAAs) have high success rates in the treatment of chronic hepatitis C virus (HCV) infection. However, 1-15% of patients fail to achieve viral eradication. Some factors may play a role in the treatment failure and relapse. In this paper, we present two cases of hepatitis C in which DAAs failed due to incomplete HCV genotyping.